Ron Kelly is the Chief Executive Officer (CEO) of Ambature, LLC.He is a performance-driven executive with over 23 years of experience in technology development, technology licensing and corporate and intellectual property law in North America and around the World.
He has extensive experience in negotiating technology licensing with large multi-national corporations such as IBM, GE, Philips, Siemens, Johnson & Johnson, Essilor Laboratories, Burmah Castrol and McKinsey. Ron has recently been very active in the US, Canada and the UK governments to help them understand the value of disruptive information technology as part of an integral part of the overall solution to creating greater quality and efficiencies in the healthcare industry.
He is the former President, CEO and Chairman of Medicalis Corporation – a leading disruptive healthcare technology company based in the Waterloo, Ontario – Canada’s technology triangle. Prior to joining Medicalis, Ron served in various board and management positions in companies involved in the licensing of various technologies, including laser vision correction technologies, non cancerous lignin polymers, e-commerce and software licensing. Ron is a graduate of Dalhousie University, Nova Scotia, with a combined Masters of Business Administration (International Business and Finance) and Juris Doctorate degrees.
He also holds an honors undergraduate degree in Finance and Management from the Memorial University of Newfoundland. On graduation, he was recruited by Canada’s largest law firm focusing on corporate finance and intellectual property for such clients as Walt Disney, Pepsi and the Government of Canada.